Clinical Trial Detail

NCT ID NCT03348904
Title Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements yes
Sponsors Incyte Corporation
Indications

non-small cell lung carcinoma

Therapies

Carboplatin + Cisplatin + Gemcitabine + Nivolumab + Paclitaxel + Pemetrexed

Carboplatin + Cisplatin + Gemcitabine + Paclitaxel + Pemetrexed

Carboplatin + Cisplatin + Epacadostat + Gemzar + Nivolumab + Taxol + Pemetrexed

Age Groups: adult senior

Additional content available in CKB BOOST